Clinical Trial Update: Nifedipine Treatment in Preterm Labor [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating nifedipine for threatened preterm labor has been withdrawn by the sponsor Hospital Clinico Universitario de Santiago.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Labor

Drugs mentioned

• Nifedipine (nifedipine)

Snippet

Sponsor: Hospital Clinico Universitario de Santiago | Conditions: Threatened Preterm Labor | Phase 3 | Status: WITHDRAWN